Last reviewed · How we verify
Allomaleic Acid (FUMARIC ACID)
At a glance
| Generic name | FUMARIC ACID |
|---|---|
| Drug class | Vitamin C [EPC] |
| Target | Egl nine homolog 1 |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
- Psoriasis
Common side effects
Key clinical trials
- A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis (PHASE4)
- Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID (PHASE2)
- PsoBest - The German Psoriasis Registry
- Swiss Dermatology Network of Targeted Therapies (SDNTT)
- A Study to Assess the Synergistic Effects of a Cranberry Beverage on Cognitive Function (NA)
- APremilast After FumaRic Acid Ester Treatment
- Modulation of the Gut-brain Axis by Cranberries: Impact on University Students' Mental Wellbeing (NA)
- Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Allomaleic Acid CI brief — competitive landscape report
- Allomaleic Acid updates RSS · CI watch RSS